Sugi Predict

Sugi Predict / Targets / SRSF7

SRSF7

Serine/arginine-rich splicing factor 7 · Q16629 · SRSF7 on Sugi Atlas →

0 patent compounds predicted against SRSF7, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SRSF7 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Valproate and Levocarnitine in Children With Spinal Muscular Atrophy PHASE3UNKNOWN
Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia PHASE2ACTIVE_NOT_RECRUITING
Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer PHASE2COMPLETED
SRSF2 Gene Mutation in Patients With t-MDS/AML nanCOMPLETED
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping nanUNKNOWN
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED
Research for Individualized Therapeutics in Rare Genetic Disease nanENROLLING_BY_INVITATION
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Clinical Study of Spinal Muscular Atrophy nanCOMPLETED
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) nanCOMPLETED
Transcriptomic Profile of Patients Treated With Different Modalities of Spinal Cord Stimulation nanUNKNOWN
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2 nanCOMPLETED
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders nanCOMPLETED
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome nanCOMPLETED
Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SRSF7 binder may also engage these)

ProteinNameSimilarity
Q3T106 — 1.000 Q3T106 →
A2RVS6 — 0.988 A2RVS6 →
Q6PDU1 — 0.987 Q6PDU1 →
Q62093 — 0.987 Q62093 →
Q5R1W5 — 0.987 Q5R1W5 →
Q06A98 — 0.986 Q06A98 →
Q69KL9 — 0.986 Q69KL9 →
O22315 — 0.986 O22315 →
Q8BL97 — 0.986 Q8BL97 →
Q3MHR5 — 0.986 Q3MHR5 →
Q3SZR8 — 0.986 Q3SZR8 →
SRSF2 Serine/arginine-rich splicing factor 2 0.985 landscape →
P30352 — 0.984 P30352 →
Q13595 — 0.984 Q13595 →
O81127 — 0.983 O81127 →
O81126 — 0.983 O81126 →
P84104 — 0.983 P84104 →
Q9LHP2 — 0.983 Q9LHP2 →
SRSF3 Serine/arginine-rich splicing factor 3 0.983 landscape →
Q6K9C3 — 0.983 Q6K9C3 →
Q9SEU4 — 0.983 Q9SEU4 →
Q18409 — 0.983 Q18409 →
Q9FYB7 — 0.982 Q9FYB7 →
TRA2B Transformer-2 protein homolog beta 0.982 landscape →
Q6PFR5 — 0.982 Q6PFR5 →
Q6K4N0 — 0.982 Q6K4N0 →
P62996 — 0.981 P62996 →
Q9V3V0 — 0.981 Q9V3V0 →
Q23121 — 0.981 Q23121 →
Q09511 — 0.981 Q09511 →